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Cell Migration in the Immune System: the Evolving
Inter-Related Roles of Adhesion Molecules and
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Leukocyte extravasation into perivascular tissue during inflammation and lymphocyte homing
to lymphoid organs involve transient adhesion to the vessel endothelium, followed by transmi-
gration through the endothelial cell (EC) layer and establishment of residency at the tissue site
for a period of time. In these processes, leukocytes undergo multiple attachments to, and detach-
ments from, the vessel-lining endothelial cells, prior to transendothelial cell migration. Transmi-
grating leukocytes must traverse a subendothelial basement membrane en route to perivascular
tissues and utilize enzymes known as matrix metalloproteinases to make selective clips in the
extracellular matrix components of the basement membrane. This review will focus on the evi-
dence for a link between adhesion of leukocytes to endothelial cells, the induction of matrix
metalloproteinases mediated by engagement of adhesion receptors on leukocytes, and the abil-
ity to utilize these matrix metalloproteinases to facilitate leukocyte invasion of tissues. Leuko-
cytes with invasive phenotypes express high levels of MMPs, and expression of MMPs
enhances the migratory and invasive properties of these cells. Furthermore, MMPs may be used
by lymphocytes to proteolytically cleave molecules such as adhesion receptors and membrane
bound cytokines, increasing their efficiency in the immune response. Engagement of leukocyte
adhesion receptors may modulate adhesive (modulation of integrin affinities and expression),
synthetic (proteinase induction and activation), and surface organization (clustering of proteo-
lyric complexes) behaviors of invasive leukocytes. Elucidation of these pathways will lead to
better understanding of controlling mechanisms in order to develop rational therapeutic
approaches in the areas of inflammation and autoimmunity.
Keywords: T lymphocyte, endothelial cell, matrix metalloproteinase, inflammation, transendothelial
migration, integrins, cell adhesion molecules
INTRODUCTION
Leukocyte Extravasation
During the processes of homing and extravasation at
sites of inflammation, circulating leukocytes become
tissue-resident cells for variable periods of time. The
transmigration of leukocytes from the bloodstream
into perivascular tissue is a critical event in both these
processes. During homing, lymphocytes bind to adhe-
sion receptors displayed on high endothelial venules
(HEV) as points of entry into secondary lymphoid
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organs (except spleen where lymphocytes enter via
blood sinusoids in the marginal zones). Granulocytes
and monocytes do not home but, along with lym-
phocytes, will adhere to the microvascular endothe-
lium in inflamed tissues, and in response to
chemoattractant or adhesive gradients, migrate across
the endothelial cell layer and accumulate at the site of
injury or infection. Both the processes of homing and
extravasation during inflammation are dynamic,
involving multiple attachments to, and detachments
from, a variety of cell types and extracellular matrix
components, before encountering antigen or anti-
gen-presenting cells in the tissues and delivering an
appropriate immunological response. The general
mechanisms involved in both processes are similar
(Reviewed in Springer, 1995a, 1995b). Briefly, the
extravasating leukocytes will first be tethered to the
endothelial cells, roll along the blood vessel wall,
integrins on the cell surface will be activated and used
to adhere tightly to the endothelial cells, leukocytes
will transmigrate across the endothelial layer, traverse
the subendothelial basement membrane, and finally
migrate into the perivascular tissue. All these steps
are mediated by binding of adhesion molecules on the
extravasating leukocytes to counter-receptors on
endothelial cells lining the vessel wall.
Initial tethering and rolling of leukocytes on the
vessel wall are mediated by a class of molecules
known as selectins, which form labile adhesions that
permit leukocytes to subsequently roll in the direction
of flow (Lawrence and Springer, 1991; Lawrence and
Springer, 1993; vonAndrian, 1991). Selectins appear
to recognize sialylated carbohydrate determinants on
their counter-receptors (Berg et al., 1991; Lasky,
1992; Rosen, 1993). L-selectin (LAM-1, MEL-14,
Leu-8) is expressed on all circulating leukocytes,
except for a subpopulation of lymphocytes (Gallatin
et al., 1983; Kansas et al., 1985; Lewinsohn et al.,
1987) and recognizes at least 2 mucin-like molecules
on HEV, GlyCAM-1 (Lasky et al., 1992) and CD34
(Baumhueter et al., 1993, 1994). CD34 is also
expressed on capillaries but is absent from most large
vessels (Fina et al., 1990). Conversely, leukocytes can
bind to E-selectin (ELAM-1) or P-selectin expressed
on endothelial cells at inflammatory sites. E-selectin
is induced on microvascular endothelial cells in
response to cytokines such as IL-1, LPS, or TNF-o
(Bevilacqua et al., 1987). Endothelial cell P-selectin is
stored in Weibel Palade bodies and rapidly mobilized
to the plasma membrane to bind neutrophils and mono-
cytes in response to mediators of acute inflammation
(Geng et al., 1990; Larsen et al., 1989; McEver et al.,
1989). E- and P-selectin recognize distinct, but closely
related ligand structures (Alon et al., 1995; Larsen et
al., 1992). A rapid selectin-ligand association rate facil-
itates the initial tethering, and a rapid dissociation rate
allows the leukocyte to roll forward (Lawrence and
Springer, 1991; Hammer and Apte, 1992).
Following rolling, given the appropriate signals,
some leukocytes will adhere tightly to the endothe-
lium via interactions between molecules of the immu-
noglobulin super-family (on the endothelial cells) and
integrins (on the leukocytes). The integrin family of
glycoproteins consists of more than 20 non-cova-
lently bound cz[3 heterodimers and bind to a diverse
array of ligands, including extracellular matrix pro-
teins, plasma proteins that are deposited at sites of
injury, such as fibrinogen, and receptors on other cells
(Hemler, 1990; Hynes, 1992). ICAM-1,-2, and-3
(Intercellular Adhesion Molecule, CD54, CD102, and
CD50) on endothelial cells binds to LFA-1 (Leuko-
cyte Function-associated Antigen, (zL32 integrin,
CD1 la/CD18) on T cells, B cells, monocytes and
neutrophils (deFourgerolles and Springer, 1992; Mar-
lin and Springer, 1987; Rothlein et al., 1986; Shimizu
et al., 1991; Staunton et al., 1989) as well as Mac-1
(aM[32 integrin, CDllb/CD18) on neutrophils and
monocytes (Diamond et al., 1990, 1991; Kishimoto et
al., 1989). VCAM-1 (Vascular Cell Adhesion Mole-
cule, CD 106) on endothelial cells binds both VLA-4
(o4[1 integrin, CD49d/CD29) and cz4137 integrin on
leukocytes (Chan et al., 1992; Elices et al., 1990;
Osborne et al., 1989; Ruegg et al., 1992; Shimizu et
al., 1991; Vennegoor et al., 1992). VLA-4 integrin
also binds to the alternatively spliced CS-1 peptide of
the extracellular matrix glycoprotein fibronectin
(Wayner et al., 1989). In addition, during lymphocyte
recirculation to mucosal tissues, the mucosal
addressin, MAdCAM-1, on Peyer’s patch HEV binds
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et al., 1992; Streeter et al., 1988). Another member of
the immunoglobulin super-family, PECAM-1 (Plate-
let Endothelial Cell Adhesion Molecule-l, CD31),
has been localized on both T cells and endothelial cell
surfaces (Newman et al., 1990; Albelda et al., 1990,
1991) and is thought to interact in a homophilic man-
ner during T cell-endothelial cell interactions (Bogen
et al., 1992). PECAM-1 has been shown to participate
in transendothelial migration and migration through
extracellular tissues by neutrophils, natural killer
cells, and monocytes (Berman et al., 1996; Christofi-
dou-Solomidou et al., 1997; Liao et al., 1995; Liao et
al., 1997; Muller, 1995).
Integrins must be activated in order to bind to the
appropriate ligands (Diamond and Springer, 1994).
Activation may be regulated by a number of extracel-
lular signals including cross-linking of the antigen
receptor, phorbol esters, binding to complement com-
ponents or to fibrinogen, or other cell-cell adhesive
interactions (Arroyo et al., 1993; Berman and Muller,
1995; Berman et al., 1996; Smith et al., 1989; Tanaka
et al., 1992; Wilkins et al., 1991). During rolling, leu-
kocytes come into contact with chemoattractants on
the microvascular endothelium, which bind G-protein
coupled receptors on leukocytes (Miller and Krangel,
1992; Springer, 1995a, 1995b) and stimulate changes
such as degranulation, shape change, actin polymeri-
zation, and respiratory burst, as well as activating the
adhesiveness of integrin molecules (Lo et al., 1989;
Smith et al., 1991). Adhesiveness of integrin mole-
cules such as Mac-1 and LFA-1 on neutrophils and
monocytes is activated by chemokines including
N-formylated peptide and IL-8. Increased adhesive-
ness is not due to changes in expression, but is likely
due to conformational changes that increase their
affinity for endothelial cell ligands (Diamond and
Springer, 1994; Landis et al., 1993; Lollo et al.,
1994). Integrin adhesiveness is transient and is
down-regulated within minutes (Dustin and Springer,
1989; Lo et al., 1989). This cycling between adhesive
and non-adhesive states allows the cells to rapidly
regulate adhesion to ligands on opposing cell surfaces
and matrices (Diamond and Springer, 1994).
Extravasating leukocytes then need to release adhe-
sive interactions with the luminal surface of the blood
vessel wall and migrate across the endothelium where
they encounter a complex, organized extracellular
matrix (ECM) comprised of several collagenous and
non-collagenous components as they migrate through
the basement membrane and into the interstitial
matrix (Shimizu & Shaw, 1991). The movement of
leukocytes across the endothelium and into the ECM
is a dynamic process in which both leukocytes and
endothelial cells actively modulate their cell-cell and
cell-ECM interactions (Madri et al., 1996). Leukocyte
migration through the ECM is mediated by a number
of parameters including integrin surface expression
(Graesser et al., 1998; Juliano & Haskill, 1993;
Leavesly et al., 1994; Romanic & Madri, 1994;
Romanic et al., 1997; Shimizu & Shaw, 1991);
integrin affinity (Arroyo et al, 1993; Hourihan et al.,
1993; Shimizu & Shaw, 1991; Smith et al., 1989;
Wilkins et al., 1991); ECM synthesis and deposition
(Hauser et al., 1993; Madri et al., 1988); and ECM
degradation (Goetzl et al., 1996; Graesser et al., 1998;
Leppert et al., 1995a, 1195b, 1996; Montgomery et al.,
1993; Romanic & Madri, 1994). In this review we will
discuss the contributions and inter-relationships of
integrin engagement and matrix metalloproteinases in
the transition of leukocytes, in particular T lym-
phocytes, from circulating cells to tissue resident cells.
Matrix metalloproteinases in leukocytes
Even with the precise combination of adhesion mole-
cules and chemokines, not all cells acquire a migra-
tory phenotype and become invasive. Several studies
have implicated MMPs as an important component in
tumor cell migration and tissue invasion (Fessler et
al., 1984; H6yhtyi et al., 1990; Liotta et al., 1979;
Mignatti et al., 1986; Salo et al., 1983). It is hypothe-
sized that, like metastasizing tumor cells, leukocytes
utilize matrix metalloproteinases (MMPs) to degrade
the extracellular matrix (ECM) components of the
basement membrane during transmigration across
blood vessel walls, and the regulation of expression
and activation ofMMPs may be critical for leukocyte
transmigration (Goetzl et al., 1996; Leppert et al.,
1995a, 1995b, 1996; Xia et al., 1996a, 1996b).
Indeed, leukocytes that have infiltrated tissues or have106 JOSEPH A. MADRI and DONNASUE GRAESSER
acquired an invasive phenotype often have elevated
expression of MMPs. Studies on cell lines from
human patients with a number of lymphoproliferative
diseases such as Burkitt’s lymphoma, B-cell lymphob-
lastic leukemia, and multiple myeloma, have found
that these "reactive" lymphoid cells express elevated
levels of either MMP-2, MMP-9 or both (Stetler-Ste-
venson et al., 1997; Vacca et al., 1998). Some of these
cell lines also express TIMP-1 or TIMP-2 (Tissue
Inhibitors of Metalloproteinases), the physiologic
inhibitors for MMP-9 and MMP-2, respectively.
MMP-9 levels are increased in the cerebral spinal
fluid of rabbits with induced bacterial meningitis, and
this increase was found to be associated with leuko-
cytes that had infiltrated the CNS (Azeh et al., 1998).
In a study of human patients with viral meningitis,
which is characterized by invasion of neutrophils,
monocytes, and lymphocytes into the subarachnoidal
space, MMP-2 levels were found to be elevated (Kolb
et al., 1998). Recently, a novel MMP, MMP-19 has
been isolated from the inflamed synovium of patients
with rheumatoid arthritis (Sedlaceck et al., 1998).
MMP-19 is also found on the surface of Jurkat lym-
phoma cells. MMP-2, MMP-9, and MMP-7 (matri-
lysin) have also been found to be up-regulated in
macrophages within inflammatory multiple sclerosis
lesions, and are believed to play a part in breakdown
of the blood-brain barrier, leukocyte emigration, and
tissue destruction in multiple sclerosis (Anthony et
al., 1997).
In addition, studies in our laboratory and others
have shown that MMPs play a role in experimental
rodent models of multiple sclerosis (Anthony et al.,
1997; Gijbels et al., 1994; Graesser et al., 1998; Hew-
son et al., 1995)
Regulation of matrix metalloproteinases via
integrin-mediated signals
The signals that regulate expression of MMPs in leu-
kocytes are largely unknown, and are the subject of
ongoing research. It is possible that signals mediated
by the engagement of leukocyte adhesion receptors
during the initial stages of transendothelial cell migra-
tion may lead to secretion or activation of MMPs in
the migrating cells. In particular, engagement of
integrin receptors is thought to trigger a number of
intracellular signaling events in T cells (Graesser et
al., 1998; Hynes, 1992; Romanic & Madri, 1994;
Romanic et al., 1997; Shimizu And Shaw, 1991). For
instance, engagement of VLA-4 either with antibod-
ies to the c4 subunit or with the alternatively spliced
CS domain of fibronectin has been shown to stimu-
late tyrosine phosphorylation of a 150 kDa protein in
T cells (Nojima et al., 1992). Ligation of VLA-4 and
VLA-5 (c5[1) integrins has been shown to act as a
costimulus along with the engagement of CD3 to
mediate T cell proliferation (Davis et al., 1990;
Nojima et al., 1990). Engagement of VLA-4 integrin
with VCAM-1 or CS1 mediates changes in the sur-
face expression of VLA-4 and LFA-1 and in adhesion
to several ECM components (Romanic & Madri,
1994; Romanic et al., 1997). In addition, engagement
of the VLA-5 integrin on T cells with fibronectin has
been shown to induce the expression of the AP-1 tran-
scription factor which regulates IL-2 transcription
(Yamada et al., 1991).
Recent data suggests that integrin-mediated signals
may also regulate MMP secretion and/or activity in a
number of cell types. For each cell type examined,
there appears to be some degree of specificity, ie. only
certain integrin engagements will induce particular
MMPs. In several tumor cell models, integrins have
been shown to play a role in transducing signals that
either enhance the expression of matrix metalloprotei-
nases, their inhibitors, or their activators (Remy et al.,
1999). In human rhabdomyosarcoma cells, antibodies
against 2 and c3 integrin subunits enhanced the
secretion of MMP-2, activation of the enzyme, and
subsequent invasion of matrigel by the cells (Kubota
et al., 1998). Ligation of c6[1 integrin on a human
melanoma cell line promoted invasiveness by causing
a 2-3 fold increase in ECM degradation (Nakahara et
al., 1996). The induced ECM degradation was associ-
ated with increased surface expression of a gelatinase
enzyme, and localization of the gelatinase at inva-
dopodia. In a similar assay, invasion of matrigel by
human glioma cells was increased by treatment with
antibodies against either 31 integrin or 5[1
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decreased expression of these integrins and increased
expression of MMP-2. Engagement of51 integrin
by binding the RGD peptide fragment of fibronectin
was found to induce stromelysin, collagenase, and
MMP-9, and increase the expression of MMP-2 in
rabbit articular chondrocytes (Arner and Tortorella,
1995). cv3 and c5[1 integrins have been shown to
play a role in human melanoma cell invasion by regu-
lating expression of MMP-2 (Seftor et al., 1992,
1993). Induction of MMPs via integrin-mediated sig-
nals has been observed in non-cancerous cells as well.
Binding of chondrocytes to RGD peptide has been
shown to induce the synthesis of stromelysin,
MMP-1, MMP-9 and increase the expression of
MMP-2. (Arner and Tortorella, 1995). In fibroblasts,
the expression of several MMPs is regulated by adhe-
sion to fibronectin (Huhtala et al., 1995; Tremble et
al, 1995) and tenascin (Tremble et al., 1994). Addi-
tionally, recent studies in our lab have shown that
MMPs induced via integrin-mediated signals play a
role in both in vivo and in vitro models for T cell
transmigration (Baron et al., 1993; Graesser et al.,
1998; Romanic and Madri, 1994).
In addition to modulation of MMP induction,
integrin engagement has been shown to affect the
activation state of MMP-2. MT-1-MMP (mem-
brane-type matrix metalloproteinase, MMP-14) is a
transmembrane metalloproteinase that has been
implicated as the molecule that both tethers and acti-
vates MMP-2 at the cell surface (Butler et al., 1998;
Cao et al., 1995; Kinoshita et al., 1998; Sato, et al.,
1994; Strongin et al., 1995). A tertiary complex is
formed between MT1-MMP, MMP-2, and TIMP-2,
which acts as a bridging molecule. In one study, the
activity of MMP-2 was increased in human breast
carcinoma cells upon adhesion to collagen I, but not
collagen IV, laminin, or fibronectin (Thompson et al.,
1994). The activation of MMP-2 in this model was
inhibited by metalloproteinase inhibitors, suggesting
that the activating enzyme is itself a metalloprotein-
ase. In a second study of breast carcinoma cells, adhe-
sion to SPARC/osteonectin and collagen was shown
to induce MMP-2 activation in cells that expressed
MT1-MMP (Gilles et al., 1998). Interestingly,
MT1-MMP was not expressed on non-invasive breast
cell counterparts, and MMP-2 activation was not
induced upon adhesion. Simultaneous induction of
MMP-2 and its activator MT1-MMP are noted during
in vitro 3-dimensional collagen matrix culture of
endothelial cells as an in vitro model of angiogenesis
(Haas et al., 1998). In this model, MMP-2 activation
is blocked with matrix metalloproteinase inhibitors,
and subsequently endothelial cell tube-formation is
arrested. Thus, the modulation of MMP activity by
integrin appears to be regulated at several levels,
including enzyme induction, enzyme activation and
enzyme inhibition. This broad range of control mech-
anisms allow for a fine-tuned tightly regulated
response during extravastion/invasion.
INTEGRIN-MEDIATED REGULATION OF
MMP-2 IN T LYMPHOCYTES
A role in T cell transmigration in vivo?
MMPs have been shown to be regulated by
integrin-mediated signals in infiltrating lymphocytes.
Studies in our lab have shown that MMP-2 is induced
or upregulated in specific T cell clones adherent to
either recombinant VCAM-1, VCAM-I(+) endothe-
lial cells, or the CS 1 peptide of fibronectin (Graesser
et al., 1998; Romanic and Madri, 1994). The induc-
tion or upregulation of MMP-2 is specifically medi-
ated by c4 integrin, and is not seen in clones adherent
to recombinant ICAM- 1, VCAM-I(-) endothelial
cells, or the RGD peptide of fibronectin. Furthermore,
the T cell clones constitutively express the enzyme
responsible for activating MMP-2 (MT1-MMP) as
well as TIMP-2, which is the "bridging" molecule
that tethers MMP-2 to cell surface MT1-MME In our
studies, upregulation of MMP-2 on the T cell surface
is always accompanied by coordinate activation of the
enzyme.
Both in vivo and in vitro models have been utilized
successfully to study the functional role of c4
integrin-mediated induction of MMP-2. Studies by
our group and others (Baron et al., 1993; Graesser et
al., 1998; Keszthelyi et al., 1996; Kuchroo et al.,108 JOSEPH A. MADRI and DONNASUE GRAESSER
1991 Soilu-Hanninen et al., 1997; Yednock et al.,
1992) strongly suggest that expression of VLA-4
(41] 1) integrin is an important determinant for T cell
entry into the central nervous system (CNS) leading
to the development of experimental autoimmune
encephalomyelitis (EAE). EAE is a rodent model for
the human disease multiple sclerosis, induced by
immunization with peptides of myelin basic protein
(MBP) or autoreactive MBP-specific CD4+ Thl cells,
characterized by invasion of the CNS by MBP-spe-
cifi T cells and ascending paralysis of the animal.
We have used a murine EAE model to study the trans-
migration of T lymphocytes from the blood into CNS
parenchyma (Baron et al., 1993; Graesser et al., 1998)
and have isolated and characterized several T cell
clones having identical antigen specificity, prolifera-
tive capacity, and cytokine profiles, but differing in
abilities to elicit disease in adoptive transfer studies.
We have found that expression of c4 integrin was a
major pathogenic factor; encephalitogenic clones
expressed ten-fold more c4 integrin than
non-encephalitogenic clones. 4 integrin high
expressors entered brain parenchyma, while 4
integrin low or null expressing clones did not. Anti-
bodies directed against either 4 integrin or its
endothelial cell counter-receptor VCAM-1 delayed
onset and reduced severity of the EAE. Furthermore,
transfection of non-encephalitogenic clones to
express 4 integrin restored the pathogenicity of the
clones.
It is likely that induction of MMP-2 is at least one
major role for 4 integrin in the disease process, as
inhibitors of MMP-2 significantly delay the onset of
disease (Graesser et al., 1998). Other investigators
observed similar effects of MMP inhibitors on EAE
disease progression in both mouse (Gijbels et al.,
1994) and rat (Hewson et al., 1995) models. T cell
clones transfected to overexpress pro-MMP-2 in the
absence of 4[1 integrin expression elicit only mod-
est transient clinical disease, while dually transfected
cells that express both MMP-2 and 4[ 1 integrin are
capable of eliciting typical, sustained EAE (Graesser,
Mahooti and Madri, J. Neuroimmunol., In Press).
mRNA and protein expression of MMP-2, MMP-7,
MMP-8, and MMP-12 are also upregulated in brain
lesions in a rat, delayed-type-hypersensitivity model
of multiple sclerosis (Anthony et al., 1998). Together,
these data suggest that regulation of expression and/or
activation of MMPs plays a role in several models of
T lymphocyte invasion into the CNS in vivo.
A role in T cell transmigration in vitro?
While informative, many times animal models fre-
quently do not lend themselves to mechanistic stud-
ies. We and others have utilized in vitro models in
which T cells are co-cultured on a monolayer of
endothelial cells and/or subendothelial matrix, mim-
icking the in vivo situation of blood vessel endothe-
lium and subendothelial basement membrane. In this
model, T cells transmigrate through the endothelial
Cell monolayer and subendothelial matrix, through a
porous membrane and into a collection well. In these
studies, both 4 integrin high-expressing and
integrin low-expressing T cell clones adhered well to
both VCAM-1 positive and VCAM- negative
endothelial cells (70% to 90%). However, high levels
of T cell transmigration were observed only when T
cells expressed significant levels of 4 integrin and
endothelial cells expressed VCAM-1, suggesting that
41 integrin engagement is necessary for T cell
transmigration (Graesser et al., 1998, Romanic and
Madri, 1994). Furthermore, these studies suggest an
inter-relationship between the presence and engage-
ment of c4l]l and the induction and activation of
MMP-2 during the process of T cell transmigration,
because specific inhibitors of MMP-2 will block the
high level of transmigration conferred by c4ll
integrin expression. Using similar in vitro models,
other groups have also found that MMP inhibitors
significantly reduce transmigration of lymphocytes
(Leppert et al., 1995a, 1995b, 1996; Xia et al., 1996a).
Further evidence for the importance of
integrin-mediated MMP regulation in T lymphocyte
transmigration comes from studies with human
peripheral blood T cells (Xia et al., 1996b). Treatment
of CD4+ T cells with VIP (vasoactive intestinal pep-
tide) leads to increased binding to fibronectin, secre-
tion of MMPs, and migration through
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against o4 or [1 integrin did not directly suppress
VIP-evoked MMP secretion, but did reduce degrada-
tion of type IV collagen by the T cells and subsequent
migration. This result suggests that engagement of
o4[ 1 integrin plays a role in regulatingMMP activity,
but not expression. This effect appears to be specific
for c4[1 integrin, as neutralizing antibodies against
o5 integrin reduced binding to fibronectin, but had no
effect on the collagen-degrading activity of the T cells
or their migration through matrigel in response to
VIE Another study has also connected MMP induc-
tion in human T cells, increased T cell transmigration
in vitro and a possible role in CNS inflammation. Pre-
treatment of human T cells with interferon [l-b
decreased interleukin-2 induced gelatinase production
and gelatinase-dependent migration across a matrix
by 90%. This study raises the possibility that the ben-
eficial effects of interferon [l-b in multiple sclerosis
patients may result from interference with the capac-
ity of autoreactive T cells to migrate into the CNS
(Yong et al., 1998).
Organization of proteolytic complexes on T cell
surfaces" A pre-requisite for transmigration?
In several recent studies investigators have demon-
strated the concentration of surface-bound proteinases
on specific areas of migrating cells (Basbaum and
Werb, 1996; Chen, 1996; Monsky et al., 1994; Naka-
hara et al., 1996) In recent studies we have observed a
similar phenomenon in T cells which have adhered to
and are initiating their migration through an endothe-
lial cell monolayer and underlying matrix (Figure 1).
Prior to adhesion to endothelial cell surfaces, o4[1
positive T cells express MT1-MMP and TIMP-2 on
their surface in diffuse patterns. However, at early
times following adhesion, o4[1 positive T cells are
seen to express MMP-2 on their cell surface, co-local-
ized with both MT1-MMP and TIMP-2. All three of
the molecules in the "activation complex" are polar-
ized to extended podosome regions on the migrating
cells, as illustrated in Figure 1. We hypothesize that
these regions will become the putative invading podo-
somes (invadopodiae) of the migrating T cells
(Graesser, Mahooti and Madri, in preparation). These
observations suggest a complex, multipoint control
system for induction, secretion, surface tethering and
activation ofMMP-2 on the T cell surface. The gener-
ation, isolation and characterization of T cell clones
having specific alterations in this migration pathway
is likely to facilitate a more complete elucidation of
this process in T cells as well as in other cell types.
Thus, the cellular mechanism(s) mediating this proc-
ess are currently undefined, but could involve activa-
tion and organization of the cytoskeleton, potentially
triggered by specific integrin (o411 and/or other
integrins) engagement and signaling as illustrated in
Figure 1.
Proteolysis of cell surface molecules: other roles
for MMPs in inflammation?
We assume infiltrating leukocytes utilize MMPs to
degrade the components of the basement membrane,
which presents a physical barrier to transmigration.
MMPs may play many additional roles in during the
inflammation process. MMPs are also capable of
cleaving membrane-bound molecules, including cell
surface adhesion molecules and cytokines. For exam-
ple, MMP-7 (matrilysin) has been found to cleave 14
integrin from the surface of human prostate carci-
noma cells (vonBredow et al., 1997). A variety of
stimuli (chemoattractants, phorbol esters, L-selectin
cross-linking) are known to simulate proteolytic
cleavage of L-selectin ("shedding") from neutrophils
and lymphocytes at a membrane-proximal extracellu-
lar domain (Jutila et al., 1989; Kishimoto et al., 1989).
The physiologic L-selectin "sheddase" enzyme is
believed to be a metalloproteinase, as shedding is
completely prevented by hydroxymate-based metallo-
proteinase inhibitors (Preece et al., 1996; Bennett et
al., 1996). In addition, L-selectin is susceptible to
cleavage by known matrix metalloproteinases,
MMP-1 and MMP-3. However, MMP-2 and MMP-9
have no effect, and L-selectin shedding is not inhib-
ited by TIMPs. Shedding of L-selectin is thought to
be an important part of the rolling mechanism, and
L-selectin-mediated leukocyte rolling is slowed by
preventing shedding (Hafezi-Maghadam and Ley,
1999; Walcheck et al., 1996). A metalloproteinase110 JOSEPH A. MADRI and DONNASUE GRAESSER
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FIGURE Representative Confocal microscopic micrograph of c4[1 high expressing T cells sixty minutes (A) and eight hours (B)
after plating on a monolayer ofVCAM-1 positive endothelial cells. A. The T cells (identified by Fluorescein labelled anti CD4) exhibit
a diffuse peripheral plasma membrane localization ofTIMP-2 (Rhodamine labelled) as well as MT1-MMP (not shown) before and after
plating onto an endothelial cell monolayer. B. After two hours, the T cells have clustered TIMP-2 to specific membrane surface regions
(Rhodamine labelled). This staining co-localizes with MT1-MMP and MMP-2 staining (data not shown), consistent with a tertiary
complex formation. C. Schematic representation of the proposed c4[l-mediated induction, assembly and activation of MT-MMP,
TIMP-2 and MMP-2 during T cell migration through the endothelium and its underlying basement membrane. Engagement of T cell
4[ elicits the induction of pro-MMP-2, followed by clustering ofMT-MMP and TIMP-2. This is followed by assembly of a tertiary
complex composed of membrane-bound MT1-MMP and TIMP-2, functioning as a tethering complex mediating binding of
pro-MMP-2. Following complex assembly, MT1-MMP activates the MMP-2 on the surface of the T cell, allowing for localized pro-
teolysis of the ECM, facilitating migration of the T cell into the perivascular tissues (see Color Plate VIII at the back of this issue)CELL MIGRATION IN THE IMMUNE SYSTEM 111
inhibitor has also been shown to block the phor-
bol-ester induced proteolytic cleavage of VCAM-1
from the cell surface of a set ofy T cells (Leca et al.,
1995). MMPs may also play other roles in T cell
immunological responses by acting on immunologi-
cally important molecules. For example, MMP-3
(stromelysin) as well as MMP-2 and MMP-9 process
IL-I[5 precursor into its biologically active form
(Schonbeck et al., 1998). Inhibition of MMPs also
block shedding of Fas ligand on T lymphocytes (Tan-
aka et al., 1998). The inter-play between adhesion
molecules, MMPs and cytokines during an inflamma-
tory responses appears to complex: adhesion through
integrins and effects of cytokines act together to regu-
late MMP activity, and in response, adhesion mole-
cules and cytokines are proteolytically cleaved by
MMPs.
CONCLUSION
The transition of T lymphocyte or other leukocytes
from circulating cells to tissue resident cells is a com-
plex process involving orchestrated engagement and
disengagement of a variety of adhesion molecules and
the initiation of several signaling cascades including
those modulating the expression and affinity of cell
surface integrins and the expression and activation of
cell surface proteolytic enzymes (Figure 2). A more
complete understanding of these processes will lead
to the development of rational therapeutic approaches
designed to beneficially modulate the inflammatory
process.
References
Albelda, S.M., Muller, W.A., Buck, C.A., Newman, EJ. (1991).
Molecular and cellular properties of PECAM-1 (endo-
CAM/CD31): a novel vascular cell-cell adhesion molecule. J.
Cell Biol. 114: 1059-1968.
Albelda, S.M., Oliver, ED., Romer, L.H., Buck, C.A. (1990). Endo-
CAM: a novel endothelial cell-cell adhesion molecule. J. Cell
Biol. ll0: 1227-1237.
Alon, R., Rossiter, H., Springer, T.A., and Kupper, T.S. (1994). Dis-
tinct cell surface ligands mediate T lymphocyte attachment
and rolling on P- and E- selectin under physiological flow. J.
Cell Biol. 127: 1485-1495.
Anthony, D.C., Ferguson, B., Matyzak, M.K., Miller, K.M., Esiri,
M.M., and Perry, V.H. (1997). Differential matrix metallopro-
teinase expression in cases of multiple sclerosis and stroke.
Neuropathol. Appl. Neurobiol. 23:406-415.
Anthony, D.C., Miller, K.M., Fearn, S., Townsend, M.J., Opde-
naker, G., Wells, G.M., Clements, J.M., Chandler, S., Gearing,
A.J., and Perry, V.H. (1998). Matrix metalloproteinase expres-
sion in an experimentally-induced DTH model of multiple
sclerosis in the rat CNS. J. Neuroimmunol. 87: 62-72.
Arner, E.C., and Tortorella, M.D. (1995). Signal transduction
through chondrocyte integrin receptors induces matrix metal-
loproteinase synthesis and synergizes with interleukin-1.
Arthritis Rheum. 38:1304-1314.
Arroyo, A.G., Garcia-Pardo, A., Sinchez-Madrid, E (1993). A high
affinity conformational state on VLA integrin heterodimers
induced by an anti-J51 chain monoclonal antibody. J. Biol.
Chem. 268: 9863-9868.
Azeh, I., Mader., M., Smirnov, A., Beuche, W., Nau, R., and Weber,
E (1998). Experimental pneumococcal meningitis in rabbits:
the increase of matrix metalloproteinase-9 in cerebrospinal
fluid correlates with leukocyte invasion.
Neurosci. Lett. 256: 127-130.
Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G., Janeway, C.A.
(1993). Surface expression of c4 integrin by CD4 T cells is
required for their entry into brain parenchyma. J. Exp. Med.
177: 57-68.
Basbaum, C.B. & Werb, Z. (1996). Focalized proteolysis: spatial
and temporal regulation of extracellular matrix degradation at
the cell surface. Curr. Opin. Cell Biol. 6:731-738.
Baumhueter, S., Singer, M.S., Henzel, W., Hemmerich, S., Renz,
M., Rosen, S.D., and Lasky, L.A. (1993). Binding of L-selec-
tin to the vascular sialomucin, CD34. Science 262: 436-438.
Baumhueter, S., Dybdal, N., Kyle, C., and Lasky, L.A. (1994). Glo-
bal vascular expression of murine CD34, a sialomucin-like
endothelial ligand for L-selectin. Blood 84: 2554-2565.
Bennet, T.A., Lynam, E.B., Sklar, L.A., and Rogelj, S. (1996).
Hydroxamate-based metalloprotease inhibitor blocks shed-
ding of L-selectin adhesion molecule from leukocytes; func-
tional consequences for neutrophil aggregation. J. Immnol.
156: 3093-3097.
Berg, E.L, Robinson, M.K., Watnock. R.A., and Butcher, E.C.
(1991). The human peripheral lymph node vascular addressin
is a ligand for LECAM-1, the peripheral lymph node homing
receptor. J. Cell Biol. 114: 343-349.
Berlin, C., Berg., E.L., Briskin, M.J., Andrew, D.P., Kilshshaw, EJ.,
Holzmann, B., Weissman, I.L., Hamann, A., and Butcher, E.C.
(1993). 47 integrin mediates lymphocyte binding to the
mucosal vascular addressin MAdCAM-1. Cell 74: 185-195.
Berman, M.E. and Muller, W.A. (1995). Ligation of plate-
let/endothelial cell adhesion molecule (PECAM-1/CD31) on
monocytes and neutrophils increases binding capacity of leu-
kocyte CR3 (CDllb/CD18). J. Immunol. 154: 299-307.
Berman, M.E., Xie, Y., and Muller, W.A. (1996). Roles of plate-
let/endothelial cell adhesion molecule- (PECAM- 1, CD31) in
natural killer cell transendothelial migration and 2 integrin
activation. J. Immunol. 156: 1515-1524.
Bevilacqua, M.E & Nelson, R.M. (1993). Selectins. J. Clin. Invest.
91: 379-387.
Bevilacqua, M.E, Pober, J.S., Mendrick, D.L., Cotran, R.S., and
Gimbrone, M.A. (1987). Identification of an inducible
endothelial-leukocyte adhesion molecule, ELAM-1. Proc.
Natl. Acad. Sci. USA. 84: 9238-9242.
Bogen, S.A., Baldwin, H.S., Watkins, S.C., Albelda, S.A, and
Abbas, A.K. (1992). Association of murine CD31 with trans-
migrating lymphocytes following antigenic stimulation. Am.
J. Pathol. 141: 843-854.112 JOSEPH A. MADRI and DONNASUE GRAESSER
VCAM-1
Increased MMP-2 Expression
MT1-MMP, TIMP-2 & MMP-2 Clustering
MMP-2 Activation
Decreased VLA-4 Expression
Decreased LFA-1 Expression
Decreased Adhesion To
VCAM-1 and ICAM-1
Increased Adhesion To Type Collagen
Type IV Collagen, Fibronectin & Laminin
Increased Residency Time in Tissue
Modulation of Phenotype
Change in Activation State
FIGURE 2 Schematic representation of the modulation of integrin expression, matrix degrading proteinases and matrix binding in T cells
upon a4[31/VCAM-1 mediated adhesion to and transmigration through endothelial cells. Following engagement of o4131 by endothelial cell
VCAM-1, the T cell exhibits down-regulation of its expression of c41 and LFA-1 and upregulation of its expression of pro-MMP-2 (72
kDa gelatinase). This is followed by formation and clustering of a tertiary complex comprised of MT1-MMP, TIMP-2 and pro-MMP-2 and
activation of MMP-2. In addition, these T cells exhibit reduced adhesion to VCAM-1 and ICAM-1 and increased adhesion to collagen types
and IV, fibronectin and laminin. Also noted were increases in endothelial cell uPA expression and activity and decreases in endothelial cell
PAI-1 expression following engagement ofVCAM-1 by c4131. This figure was generated from data appearing in Graesser et al., 1998; Madri
et al., 1996; Romanic et al., 1997 and Romanic & Madri, 1994
Butler, G., Butler, M., Atkinson, S., Will, H., Tamura, T., vanWe-
strum, S., Crabbe, T., Clements, J., d;Ortho, M. and Murphy,
G. (1998). The TIMP-2 membrane type metalloproteinase
"receptor" regulates the concentration and efficient activation
of progelatinase A: a kinetic study. J. Biol. Chem. 273: 871-
88O.
Chart, B.M.C., Elices, M.J., Murpy, E., and Hemler, M.E. (1992).
Adhesion to vascular cell adhesion molecule-1 and fibronec-
tin: comparison of o4131 (VLA-4) and a437 on the human B
cell line JY. J. Biol. Chem. 267: 8366-8370.
Chen, W.T. (1996). Proteases associated with invadopodia, and
their role in degradation of extracellular matrix. Enzyme Pro-
tein 49:59-71.
Chintala, S.K., Sawaya, R., Gokaslan, Z.L., and Rao, J.S. (1996).
Modulation of matrix metalloproteinase-2 and invasion in
human glioma cells by (x3131 integrin. Cancer Lett. 11)3: 201-
208.
Christofidou-Solomidou., M., Nakada, N.T., Williams, J., Muller,
W.A., and DeLisser, H.M. (1997). Neutrophil platelet
endothelial cell adhesion molecule-1 participates in neutrophil
recruitment at inflammatory sites and is down-regulated after
leukocyte extravasation. J. Immunol. 158: 4872-4878.
Davis, L.S., Oppenheimer-Marks, N., Bednarczyk, J.L., McIntyre,
B.W., and Lipsky, P.E. (1990). Fibronectin promotes prolifera-
tion of naive and memory T cells by signaling through both
the VLA-4 and VLA-5 integrin molecules. J. Immunol. 145:
785-793.
deFougerolles, A.R. and Springer, T.A. (1992). Intercellular adhe-
sion molecule -3, a third adhesion counter-receptor for lym-
phocyte function-associated molecule- on resting
lymphocytes. J. Exp. Med. 175: 185-190.
Diamond M.S. and Springer, T.A. (1994). The dynamic regulation
of integrin adhesiveness. Curr. Biol. 4: 506-517.
Diamond, M.S., Staunton, D.E., deFougerolles, A.R., Stacker, S.A.,
Garcia-Aguilar, J., Hibbs, M.L., and Springer, T.A. (1990).
ICAM-1 (CD54): A counter-receptor for Mac-1 (CD
llb/Cdl8). J. Cell Biol. 111: 3129-3139.CELL MIGRATION IN THE IMMUNE SYSTEM 113
Diamond, M.S., Staunton, D.E., Marlin, S.D., and Springer, T.A.
(1991). Binding of the integrin Mac-1 (CDllb/CD18) to the
third Ig-like domain of ICAM-1 (CD54) and its regulation by
glycosylation. Cell 65: 961-971.
Dustin, M.L. and Springer, T.A. (1989). T cell receptor cross-link-
ing transiently stimulates adhesiveness through LFA-1. Nature
341: 619-624.
Elices, M.J., Osborn, L., Takada, Y., Crouse, C., Luhowskyj, S.,
Hemler, M.E., Lobb, R.R. (1990). VCAM-1 on activated
endothelium interacts with the leukocyte integrin VLA-4 at a
site distinct from the VLA-4/fibronectin binding site. Cell 60:
577-584.
Fessler, L.I., Duncan, K.G., Fessler, J.H., Salo, T., Tryggvason, K.
(1984). Characterization of the procollagen IV cleavage prod-
ucts produced by a specific tumor collagenase. J. Biol. Chem.
259: 9783-9789.
Fina, L., Molgaard, H.V., Robertson, D., Bradley, N.J., Monaghan,
P., Delia, D., Sutherland, D.R., Baker, M.A., and Greaves,
M.F. (1990). Expression of the CD34 gene in vascular
endothelial cells. Blood 75:2417-2426.
Gallatin, W.M., Weissman, I.L., and Butcher, E.C. (1983). A
cell-surface molecule involved in organ-specific homing of
lymphocytes. Nature 304: 30-34.
Geng, J.G., Bevilacqua, M.P., Moore, K.L., Mclntyre, T.M., Pres-
cott, S.M., Kim, J.M., Bliss, G.A., Zimmerman, G.A., and
McEver, R.E (1990). Rapid neutrophil adhesion to activated
endothelium mediated by GMP-140. Nature 343: 30-34.
Gijbels, K., Galardy, R.E., Steinman, L., (1994). Reversal of exper-
imental autoimmune encephalomyelitis with a hydroxamate
inhibitor of matrix metalloproteinases. J. Clin. Invest. 94:
2177-2182.
Gilles, C., Bassuk, J.A., Pulyaeva, H., Sage, E.H., Foidart, J.M.,
and Thompson, E.W. (1998). SPARC/osteonectin induces
matrix metalloproteinase-2 activation in human breast cancer
cell lines. Cancer Res. 58: 5529-5536.
Goetzl, E.J., Banda, M.J., and Leppert. (1996). Matrix metallopro-
teinases in immunity. J. Immunol. 156: 1-4.
Graesser, D., Mahooti, S., Haas, T., Davis, S., Clark, R.B., and
Madri, J.A. (1998). The interrelationshipo of4 integrin and
matrix metalloproteinase-2 in the pathogenesis of experimen-
tal autoimmune encephalomyelitis. Lab. Invest. 78: 1445-
1458.
Haas, T.L., Davis, S.J., and Madri, J.A. (1998). Three-dimensional
type-1 collagen lattices induce coordinate expression of
matrix metalloproteinases MT1-MMP and MMP-2 in microv-
ascular endothelial cells. J. Biol. Chem. 273: 3604-3619.
Hafezi-Moghadam, A., and Ley, K. (1999). Relevance of L-selectin
shedding for leukocyte rolling in vivo. J. Exp. Med. 189: 939-
947.
Hammer, D.A. and Apte, S.M. (1992). Simulation of cell rolling
and adhesion on surfaces in shear flow: general results and
analysis of selectin-mediated neutrophil adhesion. Biophys. J.
Ii3: 35-57.
Hauser, I., Setter, E., Bell, L., and Madri, J.A. (1993). Fibronectin
expression correlates with U937 cell adhesion to migrating
bovine aortic endothelial cells in vitro. Amer. J. Pathol. 143:
173-179.
Hemler, M.E. (1990). VLA proteins in the integrin family: Struc-
tures, function, and their role on leukocytes. Annu. Rev.
Immunol. 8: 365-400.
Hewson, A., Smith, T., Leonard, J., and Cuzner, M. (1995). Sup-
pression of experimental allergic encephalomyelitis in the
Lew rat by the matrix metalloproteinase inhibitor R031-9790.
Inflamm. Res. 44: 345-349.
Hourihan, H., Allen, T.D., Ager, A. (1993). Lymphocyte migration
across high endothelium is associated with increases in c41
integrin (VLA-4) affinity. J. Cell. Sci. 104: 1049-1059.
H6yhtyi, M., Hujanen, E., Turpeeniemi-Hujanen, T., Thorgeirsson,
U., Liotta, L., Tryggvason, K. (1990). Modulation of type IV
collagenase activity and invasive behavior of metastatic
human melanoma (A2058) cells in vitro by monoclonal anti-
bodies to type IV collagenase. Int. J. Cancer 46: 282-286.
Hu, M.C.T., Crowe, D.T., Weissman, I.L., and Holzmann, B.
(1992). Cloning and expression of mouse integrin 15p(137): A
functional role in Peyer’s patch-specific lymphocyte homing.
Proc. Natl. Acad. Sci. USA. 89: 8254-8258.
Huhtala, E, Humphries, M., McDarthy, J., Tremble, E, Werb, Z.,
and Damsky, C. (1995). Cooperative signaling by a5[l and
a4131 integrins regulates metalloproteinase gene expression in
fibroblasts adhering to fibronectin. J. Cell Biol. 129: 867-879.
Hynes, R.O. (1992). Integrins: Versatility, modulation, and signal-
ing in cell adhesion. Cell 69:11-25.
Juliano, R.L., Haskill, S. (1993). Signal transduction from the
extracellular matrix. J Cell Biol. 120: 577-585.
Jutila, M., Torr, L., Berg, E., and Butcher, E. (1989). Function and
regulation of the neutrophil MEL-14 antigen in vivo: compari-
son with LFA-1 and MAC-1. J. Immunol. 143: 3318-3324.
Kansas, G.S., Wood, G.S., Fishwild, D.M., and Engleman, E.G.
(1985). Functional characterization of human T lymphocyte
subsets distinguished by monoclonal anti-leu-8. J. Immunol.
134: 2995-3002.
Keszthelyi, E., Karlik, S., Hyduk, S., Rice, G., Gordon, G., Yed-
nock, T., and Horner, H. (1996). Evidence for a prolonged role
of4 integrin throughout active experimental allergic enceph-
alomyelitis. Neurology 47: 1053-1059.
Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imain, K., Okada,
Y., and Seiki, M. (1998). TIMP-2 promotes activation of pro-
gelatinase A by membrane-type matrix-metalloproteinase
immobilized on agarose beads. J. Biol. Chem. 273: 16098-
16103.
Kishimoto, T., Jutila, M., Berg, E., and Butcher, E. (1989). Neu-
trophil Mac-1 and MEL-14 adhesion proteins inversely regu-
lated by chemotactic factors. Science 245: 1238-1241.
Kishimoto, T.K., Larson, R.S., Corbi, A.L., Dustin, M.L., Staunton,
D.E., and Springer, T.A. (1989). The leukocyte integrins:
LFA-1, Mac-l, and p150.95. Adv. Immunol. 46: 149-182.
Kolb, S.A., Lahrtz, E, Paul, R., Leppert, D., Nadal, D., Pfistet,
H..W., and Fontana, A. (1998). Matrix metalloproteinases and
tissue inhibitors of metalloproteinases in viral meningitis:
upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J.
Neuroimmunol. 84: 143-150.
Kubota, S., Ito, H., Ishibashi, Y., and Seyama, Y. (1997). Anti-c3
integrin antibody induces the activated form of matrix metal-
loprotease-2 (MMP-2) with concomitant stimulation of inva-
sion through matrigel by human rhabdomyosarcoma cells. Int.
J. Cancer. 70:106-111.
Kuchroo, V., Sobel, R., Yamamura, T., Greenfield, E., Dorf M., and
Lees, M. (1991). Induction of experimental allergic encepha-
lomyelitis by myelin proteolipid protein specific clones and
synthetic peptides. Pathobiol. 59:305-312.
Landis, R.C., Bennett, R.I., and Hogg, N. (1993). A novel LFA-1
activation epitope maps to the domain. J. Cell Biol. 150:
1519-1527.
Larsen, E., Celi, A., Gilbert, G.E., Furie, B.C., Erban, J.K., Bon-
fanti. R., Wagner, D.D., and Furie, B. (1989). PADGEM pro-
tein: a receptor that mediates the interaction of activated
platelets with neutrophils and monocytes. Cell. 59:305-312.114 JOSEPH A. MADRI and DONNASUE GRAESSER
Larsen, G.R., Sako, D., Ahern, T.J., Shaffer, M., Erban, J., Sajer,
S.A., Gibson, R.M., Wagner, D.D., Furie, B.C., and Furie, B.
(1992). P-selectin and E-selectin: Distinct but overlapping leu-
kocyte ligand specificities. J. Biol. Chem. 267:11101-11110.
Lasky, L.A. (1992). Selectins: interpreters of cell-specific carbohy-
drate information during inflammation. Science. 258: 964-
969.
Lasky, L.A., Singer, M.S., Dowbenko, D., lmai, Y., Henzel, W.J.,
Grimley, C., Fennie, C., Gillet., N., Watson, S.R., and Rosen,
S.D. (1992). An endothelial ligand for L-selectin is a novel
mucin-like molecule. Cell. 69: 927-938.
Lawrence, M.B. and Springer T. A. (1993). Neutrophils roll on
E-selectin. J. Immunol. 151: 6338-6346.
Lawrence, M.B. and Springer, T.A. (1991). Leukocytes roll on a
selectin at physiologic flow rates: distinction from and prereq-
uisite for adhesion through integrins. Cell. 68: 859-873.
Leavesley, D. I., Oliver, J. M., Swart, B. W., Berndt, M. C., Hay-
lock, D. N., Simmons, E J. (1994). Signals from plate-
let/endothelial cell adhesion molecule enhance the adhesive
activity of the very late antigen-4 integrin of human CD34+
hemapoietic progenitor cells. J. Immunol. 22: 4073-4083.
Leca, G., Mansur, S.E., and Bensussan, A. (1995). Expression of
VCAM-1 (CD106) by a subset of TCR gamma delta-bearing
lymphocyte clones. Involvement of a metalloprotease in the
specific hydrolytic release of the soluble isoform. J. Immunol.
154: 1069-1077.
Leppert, D., Hauser, S.L., Kishiyama, J.L., An, S., Zeng, L., and
Goetzl, E.J. (1995a). Stimulation of matrix-metalloprotein-
ase-dependent migration of T cells by eicosanoids. FASEB J.
9:1473-1481.
Leppert. D., Waubant, E., Burk, M., Okensberg, J., and Hauser, S.
(1996). Interferon l-b inhibits gelatinase secretion and in
vitro migration of human T cells; a possible mechanism for
treatment efficacy in multiple sclerosis. Ann. Neurol. 4t): 846-
852.
Leppert, D., Waubant, E., Galardy, R., Bunnet, N.W., Hauser, S.L.
(1995b). T cell gelatinases mediate basement membrane trans-
migration in vitro. J. Immunol. 154: 4379-4389.
Lewinsohn, D.M., Bargatze, R.E, and Butcher, E.C. (1987). Leuko-
cyte-endothelial cell recognition: evidence of a common
molecular mechanism shared by neutrophils, lymphocytes,
and other leukocytes. J. Immunol. 138: 4313-4321.
Liao, E, Huynh, H.K., Eiroa, A., Greene, T., Polizzi, E., and
Muller, W.A. (1995). Migration of monocytes across endothe-
lium and passage through extracellular matrix involve sepa-
rate molecular domains of PECAM-1. J. Exp. Med. 182:
1337-1343.
Liao, F., Ali, J., Greene, T., Muller, W.A. (1997). Soluble domain
of platelet-endothelial cell adhesion molecule (PECAM) is
sufficient to block transendothelial migration in vitro and in
vivo. J. Exp. Med. 185: 1349-1357.
Liotta, L.A., S. Abe, EG. Robey, Martin, G.R. (1979). Preferential
digestion of basement membrane collagen by an enzyme
derived from a metastatic murine tumor. Proc. Natl. Acad. Sci.
USA 76: 2268-2272.
Lo, S.K., Detmers, P.A., Levin, S.M., Wright, S.D. (1989). Tran-
sient adhesion of neutrophils to endothelium. J. Exp. Med.
169: 1779-1793.
Lollo, .13.A2, Chan, K.W.H., Hanson, E.M., Moy, V.T., and Brian, A.
A. (1993). Direct evidence for two affinity states for lym-
phocyte function-associated antigen-1 on activated T cells. J.
Biol. Chem. 268: 1-8.
Madri, J.A., Graesser, D., and Haas, T. (1996). The roles of adhe-
sion molecules and proteinases in lymphocyte transendothelial
migration. Biochem. Cell Biol. 74: 749-757.
Madri, J.A., Pratt, B.M., Yannariello-Brown, J. (1988). Matrix
driven cell size changes modulates aortic endothelial cell pro-
liferation and sheet migration. Amer. J. Pathol. 132: 8-27.
Marlin, S.D., and Springer, T.A. (1987) Purified intercellular adhe-
sion molecule-1 is a ligand for lymphocyte function-associ-
ated antigen (LFA-1). Cell 51: 813-819.
McEver, R.E, Beckstead, J.H., Moore, K.L., Marshall-Carlson, L.,
and Bainton, D.E (1989). GMP-140, a platelet alpha-granule
membrane protein, is also synthesized by vascular endothelial
cells and is localized in Weibel-Palade bodies. J. Clin. Invest.
84: 92-99.
Mignatti, E, Robbins, E., Rifkin, D.B. (1986). Tumor invasion
through the human amniotic membrane: requirement for a
proteinase cascade. Cell 47: 487-498.
Miller, M.D., and Krangel, M.S. (1992). Biology and biochemistry
of the chemokines: a family of chemotactic and inflammatory
cytokines. CRC Crit. Rev. Immunol. 12: 12-17.
Monsky, W.L., Lin, C.Y., Aoyama, A., Kelly, T., Akiyama, S.K.,
Mueller, S.C., and Chen, W.T. (1994). A potential marker pro-
tease of invasiveness, seprase, is localized on invadopodia of
human melanoma cells. Cancer Res. 54: 5702-5710.
Montgomery, A.M.E, Sabzevari, H., and Reisfeld, R.A. (1993).
Production and regulation of gelatinase B by human T cells.
Biochim. Biophys. Acta. 1176: 265-268.
Muller, W.A. (1995). The role of PECAM-1 in leukocyte emigra-
tion: studies in vitro and in vivo. J. Leukoc. Biol. 57: 523-528.
Nakahara, H., Nomizu, M., Akiyama, S.K., Yamada, Y., Yeh, Y.,
Chen, W.T. (1996). A mechanism for regulation of melanoma
invasion. Ligation of a6l integrin by laminin G peptides. J.
Biol. Chem. 271: 27221-27224.
Newman, EJ., Berndt, M.C., Gorski, J., White, G.C., Lyman, S.,
Paddock, C., Muller, W.A. (1990). PECAM- (CD31) cloning
and relation to adhesion molecules of the immunoglobulin
gene superfamily. Science 247: 1219-1222.
Nojima, Y., Humphries, M.J., Mould, A.E, Yamada, K.M., Schloss-
man, S.E, Morimoto, C. (1990). VLA-4 mediates
CD3-dependent CD4+ T cell activation via the CS1 alterna-
tively spliced domain of fibronectin. J. Exp. Med. 172:1185-
1192.
Nojima, Y., Rothstein, D.M., Sugita, K., Schlossman, S.F., Morim-
oto, C. (1992). Ligation of VLA-4 on T cells stimulates tyro-
sine phosphorylation of a 150 kDa protein. J. Exp. Med. 175:
1045-1053.
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S.,
Chi-Rosso, G., Lobb, R. (1989). Direct expression cloning of
vascular cell adhesion molecule-l, a cytokine-induced
endothelial protein that binds to lymphocytes. Cell. 59: 1203-
1211.
Preece, G., Murphy, G., and Ager, A. (1996). Metalloprotein-
ase-mediated regulation of L-selectin levels on leucocytes. J.
Biol. Chem. 271: 11634-11640.
Remy, L., Bellaton, C., Pourreyron, C., Anderson, W., Pereira., A.,
Deumortier, J., and Jacquier, M.F. (1999). Integrins and metal-
loproteinases: an efficient collaboration in the invasive proc-
ess. Bull. Cancer. 86: 154-158.
Romanic, A.M., Graesser, D., Visintin, I., Baron, J.L., Janeway,
C.A., and Madri, J.A. (1997). T cell adhesion to endothelial
cell adhesion molecules and extracellular matrix is modulated
upon transendothelial cell migration. Lab. Invest. 76:11-23.CELL MIGRATION IN THE IMMUNE SYSTEM 115
Romanic, A.M., Madri, J.A. (1994). The induction of 72-kD gelati-
nase in T cells upon adhesion to endothelial cells is VCAM-1
dependent. J. Cell Biol. 125:1165-1178.
Rosen, S.D. (1993). Cell surface lectins in the immune system.
Semin. Immunol. 5: 237-247.
Rothlein, R., Dustin, M.L., Marlin, S.D., and Springer, T.A. (1986).
A human intercellular adhesion molecule (ICAM-1) distinct
from LFA-1. J. Immunol. 137: 1270-1274.
Ruegg, C., Postigo, A.A., Sikorski, E.E., Butcher, E.C., Pytela, R.,
and Erle, D.J. (1992). Role of integrin 47/4p in lym-
phocyte adhesion to fibronectin and VCAM-1 and in homo-
typic cell clustering. J. Cell. Biol. 117: 179-189.
Salo, T., Liotta, L., Tryggvason, K., (1983). Purification and char-
acterization of a murine basement membrane collagen-degrad-
ing enzyme secreted by metastatic tumor cells. J. Biol. Chem.
258: 3058-3063.
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto,
E., Seiki, M. (1994). A matrix metalloproteinase expressed on
the surface of invasive tumor cells. Nature. 370: 6166.
Schonbeck, U., Mach, E, and Libby, P. (1998). Generation of bio-
logically active IL-1 by matrix metalloproteinases: a novel
caspase-l-independent pathway of IL-1 13 processing. J.
Immunol. 161: 3340-3346.
Sedlacek, R., Mauch, S., Kolb, B., Schatzlein, C., Eibel, H., Peter,
H.H., Schmitt, J., and Krawinkel, U. (1998). Matrix metallo-
proteinase MMP-19 (RASI-1) is expressed on the surface of
activated peripheral blood mononuclear cells and is detected
as an autoantigen in rheumatoid arthritis. Immunobiol. 198:
408-423.
Seftor, R.E.B., Seftor, E.A., Gehlsen, K.R., Stetler-Stevenson,
W.G., Brown, P.D., Ruoslahti, E., Hendrix, M.J.C. (1992).
Role of ov[3 integrin in human melanoma cell invasion. Proc
Natl Acad Sci USA 89: 1557-1561.
Seftor, R.E.B., Seftor, E.A., Stetler-Stevenson, W.G., Hendrix,
M.J.C. (1993). The 72 kDa type IV collagenase is modulated
via differential expression of cv[3 and 5131 integrins during
human melanoma cell invasion. Cancer Res 53: 3411-3415.
Shimizu, Y. & Shaw, S. (1991). Lymphocyte interactions with
extracellular matrix. FASEB J. 5: 2292-2299.
Smith, C.W., Kishimoto, T.K., Abass, C., Hughes, B., Rothlein, R.,
Mclntire, L.V., Butcher, E.C., and Anderson, D.C. (1991).
Chemotactic factors regulate lectin adhesion molecule
(LECAM-1)-dependent neutrophil adhesion to cytokine-stim-
ulated endothelial cells in vitro. J. Clin. Invest. 87: 609-618.
Smith, C.W., Marlin, S.D., Rothlein, R., Toman, C., and Anderson,
D.C. (1989). Cooperative interactions of LFA-1 and Mac-1
with intercellular adhesion molecule-1 in facilitating adher-
ence and transendothelial migration of human neutrophils in
vitro. J. Clin. Invest. 83:2008-2017.
Soilu-Hanninen, M., Roytta, M., Salmi, A., and Salonen, R. (1997).
Therapy with antibody against leukocyte integrin VLA-4
(CD49d) is effective and safe in virus-facilitated experimental
allergic encepahlomyelitis. J. Neuroimmunol. 72: 95-105.
Springer, T. A. (1995a). Traffic signals on endothelium for lym-
phocyte recirculation and leukocyte emigration. Annu. Rev.
Physiol. 57: 827-872.
Springer, T. A. (1995b). Signals on endothelium for lymphocyte
recirculation and leukocyte emigration: the area code para-
digm. Harvey Lect. Series. 89: 53-103.
Staunton, D.E., Marlin, S.D., Dustin, M.L., and Springer, T.A.
(1989). Functional cloning of ICAM-2, a cell adhesion ligand
for LFA-1 homologous to ICAM-1. Nature. 339: 61-64.
Stetler-Stevenson, M., Mansoor, A., Lim, M., Fukushima, P., Kehrl,
J., Marti, G., Ptaszynski, K., Wang, J., and Stetler-Stevenson,
W.G. (1997). Expression of matrix metalloproteinases and tis-
sue inhibitors of metalloproteinases in reactive and neoplastic
lymphoid cells. Blood 89: 1708-1715.
Streeter, E R., Lakey-Berg, E., Rouse, B.T.N., Bargatze, R.E, and
Butcher, E.C. (1988). A tissue-specific endothelial cell mole-
cule involved in lymphocyte homing. Nature. 331: 41-46.
Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant,
G.A., Goldberg, G.I., (1995). Mechanism of cell surface acti-
vation of 72-kDa Type IV collagenase. J. Biol. Chem. 270:
5331-5336.
Tanaka, M., Itai, T., Adachi, M., and Nagata, S. (1998). Downregu-
lation of Fas ligand by shedding. Nature Med. 4:31-36.
Tanaka, Y., Albelda, S.M., Horgan, K.J., van Seventer, G.A.,
Shimizu, Y., Newman, W., Hallam, J., Newman, P.J., Buck,
C.A., Shaw, S. (1992). CD31 expressed on distinctive T cell
subsets is a preferential amplifier of 1 integrin-mediated
adhesion. J. Exp. Med. 176: 245-253.
Thompson, E.W., Yu, M., Bueono, J., Jin, L., Maiti, S.N.,
Palao-Marco, EL., Pulyaeva, H., Tamborlane, J.W., Tirgari,
R., Wapnir, R. (1994). Collagen induced MMP-2 activation in
human breast cancer. 31: 357-370.
Tremble, E, Damsky, C., and Werb, Z. (1995). Components of the
nuclear signaling cascade that regulate collagenase gene
expression in response to integrin-driven signals. J. Cell Biol.
129: 1707-1720.
Tremble, E, Chiquet-Ehrismann, R., and Werb, Z. (1994). The
extracellular matrix ligands fibronectin and tenascin collabo-
rate in regulating collagenase gene expression in fibroblasts.
Mo. Biol. Cell. 5: 439-453.
Vacca, A., Ribatti, D., Iurlaro, M., Albini, A., Minischetti, M., Bus-
solino, R., Pellegrino, A., Ria, R., Rusnati, M., Presta., M.,
Vincenti, V., Persico, M.G., and Damacco, E (1998). Human
lymphoblastoid cells produce extracellular matrix-degrading
enzymes and induce endothelial cell proliferation, migration,
morphogenesis, and angiogenesis. Int. J. Clin. Lab. Res. 28:
55-68.
Vennegoor, C.J.G.M., van de Wiel-van Kemenade, E., Huijbens,
R.J.E, Sanchez-Madrid, E, Melief, C.J.M., Figdor, C.G.
(1992). Role of LFA-1 and VLA-4 in the adhesion of cloned
normal and LFA-1 (CDll/CD18)-deficient T cells to cultured
endothelial cells. J. Immunol. 148: 1093-1101.
vonAndrian, U.H., Chambers, J.D., McEvoy, L.M., Bargatze, R.F.,
Arfors, K.E., and Butcher, E.C. (1991). Two-step model of
leukocyte-endothelial cell interaction in inflammation: distinct
roles for LECAM-1 and the [2 integrins in vivo. Proc. Natl.
Acad. Sci. USA. 88: 7538-7542.
vonBredow, D.C., Nagle, R.B., Bowden, G.T., and Cress, A.E.
(1997). Cleavage of [4 integrin by matrilysin. Exp. Cell Res.
236:341-345.
Walcheck, B., Kahn, J., Fisher, J., Wang, B., Fisk, R., Payan, D.,
Feehan, C., Betageri, R., Darlak, K., Spatoloa, A., and Kishi-
moto, T. (1996). Neutrophil rolling altered by inhibition of
L-selectin shedding in vitro. Nature 380: 720-723.
Wayner, E.A., Garcia-Pardo, A., Humphries, M.J., McDonald, J.A.,
Carter, W.G. (1989). Identification and characterization of the
T lymphocyte adhesion receptor for an alternative cell attach-
ment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109:
1321-1330.
Wilkins, J.A., Stupack, D., Stewart, S., Ciaxia, S. (1991). [1
integrin-mediated lymphocyte adherence to extracellular
matrix is enhanced by phorbol ester treatment. Eur. J. Immu-
nol. 21: 517-522.
Xia, M., Leppert, D., Hauser, S., Sreedharan, D., Nelson, E, and
Krensky, A. (1996). Stimulus specificity of matrix metallopro-116 JOSEPH A. MADRI and DONNASUE GRAESSER
teinase: dependence of human T cell migration through a
model basement membrane. J. Immunol. 151i: 160-167.
Xia, M., Sreedharan, S.E, Dazin, E, Damsky, C.H., and Goetzl, E.J.
(1996b). Integrin-dependent role of human T cell matrix met-
alloproteinase activity in chemotaxis through a model base-
ment membrane. J. Cell Biochem. Ill: 452-458.
Yamada, A., Nikaido, T., Nojima, Y., Schlossman, S.E, Morimoto,
C. (1991). Activation of human CD4 T lymphocytes: interac-
tion of fibronectin with VLA-5 receptor on CD4 cells induces
the AP-1 transcription factor. J. Immunol. 146: 53-56.
Yednock, T.A., Cannon, C., Fritz, L.C., Sanchez-Madrid, F., Stein-
man, L., and Karin, N. (1992). Prevention of experimental
autoimmune encephalomyelitis by antibodies against 4[1
integrin. Nature 35ti: 63-66.
Yong, V.W., Chabot, S., Stuve, O., and Williams, G. (1998). Inter-
feron I] in the treatment of multiple sclerosis: mechanisms of
action. Neurology 51: 682-689.